356 related articles for article (PubMed ID: 15902400)
21. The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: implications in type 2 diabetes and islet transplantation.
Park YJ; Ao Z; Kieffer TJ; Chen H; Safikhan N; Thompson DM; Meloche M; Warnock GL; Marzban L
Diabetologia; 2013 Mar; 56(3):508-19. PubMed ID: 23262664
[TBL] [Abstract][Full Text] [Related]
22. Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity.
Karlsen AE; Rønn SG; Lindberg K; Johannesen J; Galsgaard ED; Pociot F; Nielsen JH; Mandrup-Poulsen T; Nerup J; Billestrup N
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12191-6. PubMed ID: 11593036
[TBL] [Abstract][Full Text] [Related]
23. Integrative mitogenic role of protein kinase B/Akt in beta-cells.
Trümper K; Trümper A; Trusheim H; Arnold R; Göke B; Hörsch D
Ann N Y Acad Sci; 2000; 921():242-50. PubMed ID: 11193829
[TBL] [Abstract][Full Text] [Related]
24. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207
[TBL] [Abstract][Full Text] [Related]
25. Exendin-4 protects oxidative stress-induced β-cell apoptosis through reduced JNK and GSK3β activity.
Kim JY; Lim DM; Moon CI; Jo KJ; Lee SK; Baik HW; Lee KH; Lee KW; Park KY; Kim BJ
J Korean Med Sci; 2010 Nov; 25(11):1626-32. PubMed ID: 21060752
[TBL] [Abstract][Full Text] [Related]
26. Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
Winzell MS; Ahrén B
J Mol Endocrinol; 2008 Feb; 40(2):93-100. PubMed ID: 18234911
[TBL] [Abstract][Full Text] [Related]
27. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
[TBL] [Abstract][Full Text] [Related]
28. Glucagon-like peptide-1 receptor agonist activation ameliorates venous thrombosis-induced arteriovenous fistula failure in chronic kidney disease.
Chien CT; Fan SC; Lin SC; Kuo CC; Yang CH; Yu TY; Lee SP; Cheng DY; Li PC
Thromb Haemost; 2014 Nov; 112(5):1051-64. PubMed ID: 25030617
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-1beta inhibits ATP-induced protein kinase B activation in renal mesangial cells by two different mechanisms: the involvement of nitric oxide and ceramide.
Rölz W; Xin C; Ren S; Pfeilschifter J; Huwiler A
Br J Pharmacol; 2003 Feb; 138(3):461-8. PubMed ID: 12569071
[TBL] [Abstract][Full Text] [Related]
30. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S
J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064
[TBL] [Abstract][Full Text] [Related]
31. Glucagon-like peptide-1 prevents beta cell glucolipotoxicity.
Buteau J; El-Assaad W; Rhodes CJ; Rosenberg L; Joly E; Prentki M
Diabetologia; 2004 May; 47(5):806-15. PubMed ID: 15095038
[TBL] [Abstract][Full Text] [Related]
32. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
33. Exendin-4 increases the expression of hypoxia-inducible factor-1α in rat islets and preserves the endocrine cell volume of both free and macroencapsulated islet grafts.
Jia X; Sharma A; Kumagai-Braesch M; Wernerson AM; Sörenby AK; Yamamoto S; Wang F; Tibell AB
Cell Transplant; 2012; 21(6):1269-83. PubMed ID: 22405036
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor.
Petrik J; Arany E; McDonald TJ; Hill DJ
Endocrinology; 1998 Jun; 139(6):2994-3004. PubMed ID: 9607811
[TBL] [Abstract][Full Text] [Related]
35. Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo.
Uhles S; Wang H; Bénardeau A; Prummer M; Brecheisen M; Sewing S; Tobalina L; Bosco D; Wollheim CB; Migliorini C; Sebokova E
Diabetes Obes Metab; 2011 Apr; 13(4):326-36. PubMed ID: 21205124
[TBL] [Abstract][Full Text] [Related]
36. Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanism.
Wright K; Kolios G; Westwick J; Ward SG
J Biol Chem; 1999 Jun; 274(24):17193-201. PubMed ID: 10358077
[TBL] [Abstract][Full Text] [Related]
37. TRAF2 mediates JNK and STAT3 activation in response to IL-1β and IFNγ and facilitates apoptotic death of insulin-producing β-cells.
Prause M; Berchtold LA; Urizar AI; Hyldgaard Trauelsen M; Billestrup N; Mandrup-Poulsen T; Størling J
Mol Cell Endocrinol; 2016 Jan; 420():24-36. PubMed ID: 26610752
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
[TBL] [Abstract][Full Text] [Related]
39. nitric oxide triggers the phosphatidylinositol 3-kinase/Akt survival pathway in insulin-producing RINm5F cells by arousing Src to activate insulin receptor substrate-1.
Tejedo JR; Cahuana GM; Ramírez R; Esbert M; Jiménez J; Sobrino F; Bedoya FJ
Endocrinology; 2004 May; 145(5):2319-27. PubMed ID: 14764634
[TBL] [Abstract][Full Text] [Related]
40. Exendin-4 protects hypoxic islets from oxidative stress and improves islet transplantation outcome.
Padmasekar M; Lingwal N; Samikannu B; Chen C; Sauer H; Linn T
Endocrinology; 2013 Apr; 154(4):1424-33. PubMed ID: 23471218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
